(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 5.61% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.04%.
Cooper Companies's revenue in 2024 is $3,666,300,000.On average, 8 Wall Street analysts forecast COO's revenue for 2024 to be $763,163,509,893, with the lowest COO revenue forecast at $714,171,079,669, and the highest COO revenue forecast at $771,909,780,171. On average, 8 Wall Street analysts forecast COO's revenue for 2025 to be $814,336,296,553, with the lowest COO revenue forecast at $772,351,019,121, and the highest COO revenue forecast at $823,685,792,153.
In 2026, COO is forecast to generate $860,043,682,916 in revenue, with the lowest revenue forecast at $824,906,155,737 and the highest revenue forecast at $876,415,834,298.